CRSP vs ORLY · rev $11.6M vs P/E 34, rev $9.45B
Crispr Therapeutics AG (CRSP) versus O’Reilly Automotive Inc (ORLY) — a side-by-side from cached financials, not a winner call.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
O’Reilly Automotive Inc (ORLY) is a auto parts company listed on US.
Latest reported CRSP revenue for 2026-06-30 was $11.6M. Net income was -$214.1M. CRSP currently screens at market cap $5.42B.
Latest reported ORLY revenue for 2026-06-30 was $9.45B. Net income was $1.32B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
CRSP currently screens at market cap $5.42B. ORLY currently screens at market cap $78.32B and trailing P/E 33.7.
Not investment advice. Open the CRSP and ORLY stock pages for the full models.
Not investment advice.